🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/05/2010 | 5,43 | 5,69 | 5,43 | 5,50 | +2,08% | 4,83% | 74.433 |
| 21/05/2010 | 5,46 | 5,76 | 5,24 | 5,39 | -4,64% | 9,59% | 169.090 |
| 20/05/2010 | 5,88 | 5,91 | 5,58 | 5,65 | -5,03% | 5,73% | 160.808 |
| 19/05/2010 | 6,03 | 6,06 | 5,88 | 5,95 | -1,24% | 3,10% | 129.416 |
| 18/05/2010 | 6,18 | 6,25 | 5,95 | 6,03 | -0,62% | 4,85% | 102.325 |
| 17/05/2010 | 6,29 | 6,36 | 6,03 | 6,06 | -2,41% | 5,36% | 92.092 |
| 14/05/2010 | 6,18 | 6,29 | 6,10 | 6,21 | -0,60% | 3,03% | 95.592 |
| 13/05/2010 | 6,29 | 6,29 | 6,03 | 6,25 | -1,18% | 4,17% | 149.693 |
| 12/05/2010 | 6,21 | 6,48 | 5,95 | 6,33 | +1,81% | 8,44% | 305.559 |
| 11/05/2010 | 6,18 | 6,21 | 6,03 | 6,21 | +0,00% | 3,03% | 269.918 |
| 10/05/2010 | 6,18 | 6,33 | 6,06 | 6,21 | +3,75% | 4,24% | 261.556 |
| 07/05/2010 | 6,40 | 6,66 | 5,99 | 5,99 | -5,88% | 10,53% | 292.922 |
| 06/05/2010 | 6,70 | 6,77 | 6,36 | 6,36 | -8,11% | 6,14% | 225.355 |
| 05/05/2010 | 7,04 | 7,04 | 6,81 | 6,92 | -1,60% | 3,19% | 112.798 |
| 04/05/2010 | 7,00 | 7,07 | 7,00 | 7,04 | +0,53% | 1,07% | 143.388 |
| 03/05/2010 | 6,89 | 7,11 | 6,89 | 7,00 | +1,63% | 3,26% | 96.314 |
| 30/04/2010 | 7,04 | 7,19 | 6,81 | 6,89 | -2,64% | 5,32% | 107.748 |
| 29/04/2010 | 7,07 | 7,15 | 7,04 | 7,07 | +0,53% | 1,59% | 89.100 |
| 28/04/2010 | 7,07 | 7,11 | 7,04 | 7,04 | +0,00% | 1,06% | 62.570 |
| 27/04/2010 | 7,07 | 7,19 | 6,96 | 7,04 | -1,05% | 3,17% | 102.218 |
| 26/04/2010 | 7,07 | 7,26 | 7,04 | 7,11 | +1,06% | 3,17% | 147.022 |
| 23/04/2010 | 6,85 | 7,11 | 6,77 | 7,04 | +2,73% | 4,92% | 153.033 |
| 22/04/2010 | 6,70 | 6,85 | 6,59 | 6,85 | +2,24% | 3,91% | 90.382 |
| 21/04/2010 | 6,70 | 6,74 | 6,63 | 6,70 | +0,56% | 1,68% | 50.174 |
| 20/04/2010 | 6,59 | 6,70 | 6,51 | 6,66 | +1,71% | 2,84% | 108.523 |
| 19/04/2010 | 6,66 | 6,81 | 6,55 | 6,55 | -1,69% | 3,93% | 120.946 |
| 16/04/2010 | 6,63 | 6,81 | 6,51 | 6,66 | +0,56% | 4,52% | 84.638 |
| 15/04/2010 | 6,44 | 6,63 | 6,36 | 6,63 | +2,91% | 4,07% | 77.238 |
| 14/04/2010 | 6,48 | 6,51 | 6,40 | 6,44 | +0,58% | 1,73% | 46.914 |
| 13/04/2010 | 6,40 | 6,48 | 6,36 | 6,40 | -0,58% | 1,75% | 69.677 |